INSIGHTS ON DRUG DEVELOPMENT
-
Overcoming Challenges To High-Concentration Formulation Development
Explore how the S-HiCon™ platform optimizes high-concentration therapeutic antibody formulations, overcoming stability and manufacturability challenges to deliver safe, effective therapies.
-
Advancing Infectious Disease Research With This ddPCR System
Efficient digital PCR workflows maximize data from 5µL samples. Achieve high-level multiplexing and faster turnaround times to accelerate discovery and verify NGS findings with total confidence.
-
Development Of A High Sensitivity SPE-LC-MS/MS Assay
Achieve ultra-sensitive glucagon quantification with ionKey/MS, μElution SPE, and advanced MS fragmentation to deliver low LOD, reduced sample loss, and enhanced confidence in results.
-
Transforming Research Through Lab Automation
Self-driving labs bring automation and AI together to transform research. Learn about how continuous experimentation and real-time learning unlock faster insights and more efficient paths to innovation.
-
Comprehensive And Streamlined Genomic Signature Assessment6/9/2026
Simultaneous analysis of HRD, TMB, and MSI offers a more complete view of tumor biology. A modular sequencing approach enables efficient workflows, conserves samples, and delivers deeper insights.
-
Screening For Amorphous Drug Substance5/6/2026
Incorporate amorphous form screening early in development to unlock solubility advantages, improve bioavailability, and accelerate your path to market.
-
Enhanced Validation Data Anti-EGFRvIII Recombinant Antibody3/24/2025
Select the right antibody clone by exploring enhanced validation data for top recombinant antibody clones that offer comprehensive specificity and sensitivity insights tailored to your project's unique requirements.
-
Quantification Of Semaglutide With A Reliable Analytical Method7/17/2025
Explore a validated LC-MS/MS method for precise Semaglutide quantification in plasma, which features enhanced sensitivity, peak definition, and reproducibility using innovative technologies.
-
Overcoming Challenges In Ophthalmic Formulations8/27/2025
Discover key strategies for overcoming formulation challenges in ophthalmic drug development and learn how selecting the right excipients supports quality, compliance, and safety.
DRUG DEVELOPMENT SOLUTIONS
-
AST’s line of table-top machines, GENiSYS® Lab, are ideal systems for drug product development and cGMP production applications. Each system is designed to automate the critical aseptic operations for vial, syringe and cartridge processing to reduce contamination risk and product variability. These table-top systems are engineered to have complete compatibility with cleanroom environments, including Laminar Air Flow Hoods, Bio-Safety Cabinets and aseptic isolators.
-
A60 F Stereo Microscope
Optimize your productivity and production quality
The intuitive A60 F and A60 S stereo microscopes fulfill what you need – high sample throughput, optimum visibility of product details and components, and easy processing of subassemblies.
-
See 80% more of your sample with a 46 mm object field
-
Comfortable access your sample due to the 122 mm working distance
-
Easy handling, less refocusing and time saving with up to 13.6 mm depth of field and Leica FusionOptics technology
-
Enables large surface overview and detailed observation with a magnification range from 5x to 30x
-
-
Poor solubility derails ~80% of molecules. Thermo Fisher Scientific's Quadrant 2 platform uses AI/ML to predict the right formulation strategy before lab work begins.
-
Enhance drug solubility and bioavailability with an advanced mesoporous silica excipient that stabilizes poorly soluble compounds in their amorphous form and is backed by strong regulatory and quality support.
-
We offer mRNA drug substance, formulated bulk drug product manufacturing (encapsulation), and fill/finish from a single site.